Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021135
Company: AM REGENT
Company: AM REGENT
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| VENOFER | IRON SUCROSE | EQ 100MG IRON/5ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS | Prescription | AB | Yes | Yes |
| VENOFER | IRON SUCROSE | EQ 50MG IRON/2.5ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS | Prescription | AB | Yes | No |
| VENOFER | IRON SUCROSE | EQ 75MG IRON/3.75ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
| VENOFER | IRON SUCROSE | EQ 200MG IRON/10ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS | Prescription | AB | Yes | No |
| VENOFER | IRON SUCROSE | EQ 65MG IRON/3.25ML (EQ 20MG IRON/ML) | INJECTABLE;INTRAVENOUS | Discontinued | None | No | No |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 03/02/2026 | SUPPL-42 | Manufacturing (CMC)-Packaging | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/021135Orig1s042lbl.pdf | |
| 08/01/2024 | SUPPL-38 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021135s038lbl.pdf | |
| 01/20/2021 | SUPPL-37 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021135Orig1s037lbl.pdf | |
| 01/20/2021 | SUPPL-37 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021135Orig1s037lbl.pdf | |
| 09/11/2020 | SUPPL-36 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021135s036lbl.pdf | |
| 12/19/2018 | SUPPL-35 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021135s035lbl.pdf | |
| 11/28/2017 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021135s032lbl.pdf | |
| 11/28/2017 | SUPPL-32 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/021135s032lbl.pdf | |
| 03/29/2013 | SUPPL-23 | Manufacturing (CMC) | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021135s023lbl.pdf |
| 09/21/2012 | SUPPL-24 | Efficacy-Pediatric | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021135s024lbl.pdf | |
| 06/22/2011 | SUPPL-20 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021135s020lbl.pdf | |
| 12/03/2007 | SUPPL-17 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021135s017lbl.pdf | |
| 02/09/2007 | SUPPL-15 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021135s015lbl.pdf | |
| 02/09/2007 | SUPPL-15 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/021135s015lbl.pdf | |
| 10/17/2005 | SUPPL-13 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021135s013lbl.pdf | |
| 06/17/2005 | SUPPL-8 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021135s008lbl.pdf | |
| 07/26/2002 | SUPPL-5 | Manufacturing (CMC)-Control | Label (PDF) | This supplement type does not usually require new labeling. | https://www.accessdata.fda.gov/drugsatfda_docs/label/2003/21135se2-005ltr.pdf |
| 11/06/2000 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2000/21135lbl.pdf |